| Drug General Information |
| Drug ID |
D0C7PY
|
| Former ID |
DNC002636
|
| Drug Name |
Lauryl Dimethylamine-N-Oxide
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C14H31NO
|
| Canonical SMILES |
CCCCCCCCCCCC[N+](C)(C)[O-]
|
| InChI |
1S/C14H31NO/c1-4-5-6-7-8-9-10-11-12-13-14-15(2,3)16/h4-14H2,1-3H3
|
| InChIKey |
SYELZBGXAIXKHU-UHFFFAOYSA-N
|
| PubChem Compound ID |
|
| PubChem Substance ID |
841715, 4761191, 5118841, 7888620, 8161595, 10586704, 15172361, 24865072, 24865076, 24865079, 26757705, 29283393, 46506355, 48413663, 48417818, 49857335, 57329008, 57649943, 57649946, 57649948, 78834387, 91695002, 104250135, 104337146, 123106423, 125331208, 126674895, 129305719, 134980355, 137007768, 137640972, 143290336, 152043453, 160967205, 162187894, 162765302, 163812013, 164779473, 174558837, 175266506, 176331637, 179686311, 204365243, 204937206, 223661035, 225097857, 226414953, 241178787, 242081717, 252409530
|
| Target and Pathway |
| Target(s) |
Rhodopsin |
Target Info |
Inhibitor |
[1]
|
|---|
| Amine oxidase [flavin-containing] B |
Target Info |
Inhibitor |
[1]
|
| Dihydroorotate dehydrogenase, mitochondrial |
Target Info |
Inhibitor |
[1]
|
|
BioCyc Pathway
|
Superpathway of tryptophan utilization
|
|
Tryptophan degradation via tryptamine
|
|
Dopamine degradation
|
|
Putrescine degradation III
|
|
Noradrenaline and adrenaline degradation
|
|
KEGG Pathway
|
Phototransductionhsa00260:Glycine, serine and threonine metabolism
|
|
Arginine and proline metabolism
|
|
Histidine metabolism
|
|
Tyrosine metabolism
|
|
Phenylalanine metabolism
|
|
Tryptophan metabolism
|
|
Drug metabolism - cytochrome P450
|
|
Metabolic pathways
|
|
Serotonergic synapse
|
|
Dopaminergic synapse
|
|
Cocaine addiction
|
|
Amphetamine addiction
|
|
Alcoholismhsa00240:Pyrimidine metabolism
|
|
PANTHER Pathway
|
Heterotrimeric G-protein signaling pathway-rod outer segment phototransductionP00001:Adrenaline and noradrenaline biosynthesis
|
|
5-Hydroxytryptamine degredation
|
|
Dopamine receptor mediated signaling pathway
|
|
Pathway Interaction Database
|
Visual signal transduction: Rodsalphasynuclein_pathway:Alpha-synuclein signaling
|
|
PathWhiz Pathway
|
Pyrimidine Metabolism
|
|
Reactome
|
The canonical retinoid cycle in rods (twilight vision)
|
|
Inactivation, recovery and regulation of the phototransduction cascade
|
|
G alpha (i) signalling eventsR-HSA-500753:Pyrimidine biosynthesis
|
|
WikiPathways
|
GPCRs, Class A Rhodopsin-like
|
|
Visual phototransduction
|
|
Regulation of Microtubule Cytoskeleton
|
|
Integrated Breast Cancer Pathway
|
|
Integrin-mediated Cell AdhesionWP465:Tryptophan metabolism
|
|
Dopamine metabolism
|
|
Phase 1 - Functionalization of compoundsWP1851:Metabolism of nucleotides
|
| References |
| REF 1 | How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. |
|---|
